vs
Side-by-side financial comparison of Consolidated Edison (ED) and NovaBay Pharmaceuticals, Inc. (NBY). Click either name above to swap in a different company.
NovaBay Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($4.8M vs $4.0M, roughly 1.2× Consolidated Edison). On growth, NovaBay Pharmaceuticals, Inc. posted the faster year-over-year revenue change (126.1% vs 8.9%). Over the past eight quarters, NovaBay Pharmaceuticals, Inc.'s revenue compounded faster (42.5% CAGR vs -96.5%).
Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc.
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
ED vs NBY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $4.0M | $4.8M |
| Net Profit | — | $-1.2M |
| Gross Margin | — | 65.2% |
| Operating Margin | 12.2% | -37.2% |
| Net Margin | — | -25.5% |
| Revenue YoY | 8.9% | 126.1% |
| Net Profit YoY | — | 70.5% |
| EPS (diluted) | $0.82 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.0M | — | ||
| Q4 25 | $4.0B | — | ||
| Q3 25 | $4.6B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $4.9B | — | ||
| Q4 24 | $3.7B | $4.8M | ||
| Q3 24 | $4.2B | $0 | ||
| Q2 24 | $3.3B | $2.4M |
| Q1 26 | — | — | ||
| Q4 25 | $298.0M | — | ||
| Q3 25 | $688.0M | — | ||
| Q2 25 | $246.0M | — | ||
| Q1 25 | $791.0M | — | ||
| Q4 24 | $310.0M | $-1.2M | ||
| Q3 24 | $588.0M | $-1.2M | ||
| Q2 24 | $202.0M | $-1.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 65.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 66.3% |
| Q1 26 | 12.2% | — | ||
| Q4 25 | 12.3% | — | ||
| Q3 25 | 21.2% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | 23.0% | — | ||
| Q4 24 | 13.0% | -37.2% | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 9.7% | -67.4% |
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | — | ||
| Q3 25 | 15.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 16.2% | — | ||
| Q4 24 | 8.5% | -25.5% | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | 6.1% | -66.0% |
| Q1 26 | $0.82 | — | ||
| Q4 25 | $0.81 | — | ||
| Q3 25 | $1.90 | — | ||
| Q2 25 | $0.68 | — | ||
| Q1 25 | $2.25 | — | ||
| Q4 24 | $0.89 | — | ||
| Q3 24 | $1.69 | $-1.92 | ||
| Q2 24 | $0.58 | $-1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $430.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-129.0K |
| Total Assets | — | $3.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $181.0M | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $360.0M | — | ||
| Q4 24 | $1.3B | $430.0K | ||
| Q3 24 | $93.0M | $776.0K | ||
| Q2 24 | $1.5B | $751.0K |
| Q1 26 | — | — | ||
| Q4 25 | $25.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $24.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $24.2B | — | ||
| Q3 25 | $24.2B | — | ||
| Q2 25 | $23.8B | — | ||
| Q1 25 | $23.8B | — | ||
| Q4 24 | $22.0B | $-129.0K | ||
| Q3 24 | $21.9B | $1.1M | ||
| Q2 24 | $21.6B | $-617.0K |
| Q1 26 | — | — | ||
| Q4 25 | $74.6B | — | ||
| Q3 25 | $71.8B | — | ||
| Q2 25 | $71.5B | — | ||
| Q1 25 | $70.7B | — | ||
| Q4 24 | $70.6B | $3.4M | ||
| Q3 24 | $68.6B | $3.9M | ||
| Q2 24 | $67.9B | $3.9M |
| Q1 26 | — | — | ||
| Q4 25 | 1.07× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -35.4% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $504.0M | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $837.0M | — | ||
| Q4 24 | $1.3B | $-1.7M | ||
| Q3 24 | $392.0M | $-2.4M | ||
| Q2 24 | $1.3B | $-1.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -35.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.97× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 8.04× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.23× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 6.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ED
| Electric | $2.9M | 72% |
| Gas | $923.0K | 23% |
| Other | $187.0K | 5% |
| Non-utility | $1.0K | 0% |
NBY
| Other | $2.4M | 51% |
| Total Product Revenue | $2.3M | 49% |
